doi: 10.1007/pl00011257.
Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae
Affiliations
- PMID: 11347679
- DOI: 10.1007/pl00011257
Item in Clipboard
Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae
Eur J Clin Microbiol Infect Dis.
2001 Mar.
No abstract available
Similar articles
-
In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis.J Infect Dis. 1999 Aug;180(2):555-8. doi: 10.1086/314888. J Infect Dis. 1999. PMID: 10395882
-
In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae.Eur J Clin Microbiol Infect Dis. 2001 Apr;20(4):271-5. doi: 10.1007/pl00011264. Eur J Clin Microbiol Infect Dis. 2001. PMID: 11399019
-
Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates.J Antimicrob Chemother. 2000 Jan;45(1):31-9. doi: 10.1093/jac/45.1.31. J Antimicrob Chemother. 2000. PMID: 10629010
-
Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.J Antimicrob Chemother. 2000 Jun;45(6):771-5. doi: 10.1093/jac/45.6.771. J Antimicrob Chemother. 2000. PMID: 10837428
-
Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae.Antimicrob Agents Chemother. 2001 Jun;45(6):1911-4. doi: 10.1128/AAC.45.6.1911-1914.2001. Antimicrob Agents Chemother. 2001. PMID: 11353652 Free PMC article.
Cited by
-
Moxifloxacin: a review of its use in the management of bacterial infections.Drugs. 2004;64(20):2347-77. doi: 10.2165/00003495-200464200-00006. Drugs. 2004. PMID: 15456331 Review.
-
Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis.Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):832-8. doi: 10.1007/s10096-005-0037-3. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16331335
-
Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis.Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):656-62. doi: 10.1007/s10096-003-1016-1. Epub 2003 Oct 14. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14557920
-
Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.Antimicrob Agents Chemother. 2008 Mar;52(3):822-30. doi: 10.1128/AAC.00731-07. Epub 2007 Dec 26. Antimicrob Agents Chemother. 2008. PMID: 18160515 Free PMC article.
-
New species genetic approach to identify strains of mitis group streptococci that are donors of rifampin resistance to Streptococcus pneumoniae.Antimicrob Agents Chemother. 2011 Jan;55(1):368-72. doi: 10.1128/AAC.00856-10. Epub 2010 Nov 1. Antimicrob Agents Chemother. 2011. PMID: 21041504 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
